-

VIDEO

PhRMA's Dr. Chin talks about Diabetes

PhRMA Executive VP and Chief Medical Officer William Chin M.D. talks about new and exciting therapies for diabetes.

RELATEDResources

default_1000x635_press-release

-

Press Release

Report Outlines Many New Medicines in Development to Battle Diabetes Epidemic Affecting More than 30 Million Americans

A new report highlights continued progress and ongoing efforts in the research and development of new treatments for the more than 30 million Americans with diabetes and diabetes-related conditions. According to the report, there are now more than 170 medicines in development for type 1 diabetes, type 2 diabetes and related diseases.

The logo of The Catalyst, a blog about America's biopharmaceutical industry from Pharmaceutical Research and Manufacturers of America, or PhRMA
Blog Post

New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Because diabetes is the seventh leading cause of death in the United States, the need for innovative treatments and therapies is greater than it ever has been. America’s biopharmaceutical companies are committed to developing new and innovative medicines for patients in need.